JP2011105738A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011105738A5 JP2011105738A5 JP2011010997A JP2011010997A JP2011105738A5 JP 2011105738 A5 JP2011105738 A5 JP 2011105738A5 JP 2011010997 A JP2011010997 A JP 2011010997A JP 2011010997 A JP2011010997 A JP 2011010997A JP 2011105738 A5 JP2011105738 A5 JP 2011105738A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- pharmaceutically acceptable
- acceptable salt
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NRLBHPLWMGCODT-UHFFFAOYSA-N CC(C)C(N(c(cc1)ccc1C#N)C(c1ccc2O)=O)=Nc1c2OC Chemical compound CC(C)C(N(c(cc1)ccc1C#N)C(c1ccc2O)=O)=Nc1c2OC NRLBHPLWMGCODT-UHFFFAOYSA-N 0.000 description 1
Claims (6)
- 遊離型または薬学的に許容される塩形態の、
- 遊離型または薬学的に許容される塩形態の、次式
- 遊離型または薬学的に許容される塩形態の、次式
- 遊離型または薬学的に許容される塩形態の、次式
- 化合物が遊離型である、請求項１〜４のいずれかに記載の医薬組成物。
- 化合物が薬学的に許容される塩形態である、請求項１〜４のいずれかに記載の医薬組成物。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0412769.2A GB0412769D0 (en) | 2004-06-08 | 2004-06-08 | Organic compounds |
| GB0412769.2 | 2004-06-08 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007526311A Division JP4703650B2 (ja) | 2004-06-08 | 2005-06-08 | バニロイドアンタゴニストとして有用なキナゾリノン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011105738A JP2011105738A (ja) | 2011-06-02 |
| JP2011105738A5 true JP2011105738A5 (ja) | 2012-03-08 |
| JP5400812B2 JP5400812B2 (ja) | 2014-01-29 |
Family
ID=32696854
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007526311A Active JP4703650B2 (ja) | 2004-06-08 | 2005-06-08 | バニロイドアンタゴニストとして有用なキナゾリノン誘導体 |
| JP2011010997A Active JP5400812B2 (ja) | 2004-06-08 | 2011-01-21 | バニロイドアンタゴニストとして有用なキナゾリノン誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007526311A Active JP4703650B2 (ja) | 2004-06-08 | 2005-06-08 | バニロイドアンタゴニストとして有用なキナゾリノン誘導体 |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US7960399B2 (ja) |
| EP (1) | EP1755606B2 (ja) |
| JP (2) | JP4703650B2 (ja) |
| KR (2) | KR20100101017A (ja) |
| CN (1) | CN1956721B (ja) |
| AT (1) | ATE376833T1 (ja) |
| AU (2) | AU2005251476C1 (ja) |
| BR (1) | BRPI0511933B8 (ja) |
| CA (1) | CA2567821C (ja) |
| CY (1) | CY1107846T1 (ja) |
| DE (1) | DE602005003128T3 (ja) |
| DK (1) | DK1755606T4 (ja) |
| EC (2) | ECSP067067A (ja) |
| ES (1) | ES2293584T5 (ja) |
| GB (1) | GB0412769D0 (ja) |
| HK (1) | HK1105577A1 (ja) |
| HR (1) | HRP20070577T4 (ja) |
| IL (1) | IL179532A (ja) |
| MA (1) | MA28685B1 (ja) |
| MX (1) | MXPA06014249A (ja) |
| NO (1) | NO338181B1 (ja) |
| NZ (1) | NZ551630A (ja) |
| PL (1) | PL1755606T5 (ja) |
| PT (1) | PT1755606E (ja) |
| RU (2) | RU2396261C2 (ja) |
| SG (1) | SG153811A1 (ja) |
| SI (1) | SI1755606T2 (ja) |
| TN (1) | TNSN06405A1 (ja) |
| WO (1) | WO2005120510A1 (ja) |
| ZA (1) | ZA200609634B (ja) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0412769D0 (en) | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
| GB0525068D0 (en) * | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| KR20090043583A (ko) | 2006-08-23 | 2009-05-06 | 뉴로젠 코포레이션 | 2-펜옥시 피리미디논 유사체 |
| CA2668579A1 (en) * | 2006-11-06 | 2008-06-05 | Neurogen Corporation | Cis-cyclohexyl substituted pyrimidinone derivatives |
| KR20100039410A (ko) * | 2007-07-18 | 2010-04-15 | 노파르티스 아게 | Ｖｒ－１ 길항제 및 ｃｏｘ－２ 억제제의 상승적 조합물 |
| US8915362B2 (en) | 2008-10-08 | 2014-12-23 | Ultimed, Inc. | Sharps container |
| US8349852B2 (en) * | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| JP2013518085A (ja) | 2010-02-01 | 2013-05-20 | ノバルティス アーゲー | ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体 |
| WO2011092293A2 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
| WO2011095450A1 (en) | 2010-02-02 | 2011-08-11 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
| UY34094A (es) | 2011-05-27 | 2013-01-03 | Novartis Ag | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina |
| AU2013255458A1 (en) | 2012-05-03 | 2014-10-09 | Novartis Ag | L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists |
| EP2964618B1 (en) * | 2013-03-05 | 2019-09-04 | University Of Notre Dame Du Lac | Quinazolinone antibiotics |
| US10016425B2 (en) | 2016-11-03 | 2018-07-10 | King Saud University | Anti-ulcerative colitis compound |
| TWI721623B (zh) | 2018-10-31 | 2021-03-11 | 美商基利科學股份有限公司 | 經取代之6-氮雜苯并咪唑化合物 |
| TWI721624B (zh) | 2018-10-31 | 2021-03-11 | 美商基利科學股份有限公司 | 經取代之6-氮雜苯并咪唑化合物 |
| JP6994061B2 (ja) * | 2019-02-15 | 2022-01-14 | ノバルティス アーゲー | ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの製剤 |
| JP2022520410A (ja) | 2019-02-15 | 2022-03-30 | ノバルティス アーゲー | ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤 |
| CN113453686A (zh) | 2019-02-15 | 2021-09-28 | 诺华股份有限公司 | 治疗眼表痛的方法 |
| TWI826690B (zh) | 2019-05-23 | 2023-12-21 | 美商基利科學股份有限公司 | 經取代之烯吲哚酮化物及其用途 |
| RU2755206C1 (ru) | 2020-05-20 | 2021-09-14 | Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) | Средство пролонгированного анальгетического действия и лекарственный препарат на его основе |
| JP2023536938A (ja) | 2020-08-06 | 2023-08-30 | ノバルティス アーゲー | ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤 |
| US20230416207A1 (en) * | 2020-11-17 | 2023-12-28 | Crystal Pharmatech Co., Ltd. | Crystalline forms of quinazolinone compound and process for preparing the same |
| UY39681A (es) | 2021-03-26 | 2022-10-31 | Novartis Ag | Derivados de ciclobutilo 1,3–sustituidos y sus usos |
| WO2024062389A1 (en) | 2022-09-21 | 2024-03-28 | Bausch + Lomb Ireland Limited | Crystalline polymorph forms of a trpv1 antagonist and formulations thereof |
Family Cites Families (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US49728A (en) * | 1865-09-05 | Improvement | ||
| US95650A (en) * | 1869-10-12 | Improvement in machines for bending sheet-metal for cornices | ||
| US82365A (en) * | 1868-09-22 | thompson | ||
| US220227A (en) * | 1879-10-07 | Improvement in stri klng-movements for clocks | ||
| DE239090C (ja) | 1906-11-01 | |||
| US2749344A (en) | 1953-01-02 | 1956-06-05 | Burroughs Wellcome Co | Pyrimidine compounds |
| DE1224316B (de) | 1961-03-18 | 1966-09-08 | Beiersdorf & Co Ag P | Verfahren zur Herstellung von 2-Methyl-3-(o-aethylphenyl)-4-oxo-3, 4-dihydrochinazolin und dessen Salzen |
| DE1232152B (de) * | 1962-06-27 | 1967-01-12 | Heyden Chem Fab | Verfahren zur Herstellung von 3-Phenylchinazolinon-(4)-derivaten |
| US3515787A (en) * | 1962-06-27 | 1970-06-02 | Squibb & Sons Inc | Compositions and methods for producing a muscle relaxing effect in an animal with 2,3 - substituted - 6 - amino-4-quinazolones |
| GB1003802A (en) * | 1963-06-04 | 1965-09-08 | Searle & Co | Pyrimidinone derivatives |
| DE1280874B (de) * | 1963-10-09 | 1968-10-24 | Boehringer Sohn Ingelheim | 2-Methyl-3-(2-dimethylaminophenyl)-8-amino-3H-chinazolon-(4) |
| US3317388A (en) | 1964-11-20 | 1967-05-02 | Wallace & Tiernan Inc | Methods for treating pain |
| US3864362A (en) | 1970-05-27 | 1975-02-04 | Chinoin Gyogyszer Es Vegyeszet | Iso flavones |
| BE793594A (fr) | 1972-01-03 | 1973-07-02 | Pfizer | Nouvelles 6,7-dimethoxyquinazolines utiles comme analgesiques et tranquillisants |
| GB1495305A (en) | 1975-09-12 | 1977-12-14 | Pfizer Ltd | 3-phenyl-4-oxo-4h-benzopyran derivatives |
| US4501755A (en) | 1981-05-01 | 1985-02-26 | Pennwalt Corporation | Isoflavones useful as anti-inflammatory agents |
| JPS59128376A (ja) * | 1983-01-13 | 1984-07-24 | Tanabe Seiyaku Co Ltd | キナゾリノン誘導体 |
| SU1262927A1 (ru) | 1985-01-09 | 1997-11-20 | Институт физико-органической химии и углехимии АН УССР | Способ получения 6-бром-5-метилимидазо(4,5-в)пиридина |
| JPS62201882A (ja) | 1985-11-18 | 1987-09-05 | Yamanouchi Pharmaceut Co Ltd | イソフラボン誘導体 |
| JPS62193605A (ja) * | 1986-02-20 | 1987-08-25 | Toray Ind Inc | 半透性複合膜の製造方法 |
| ZA873745B (en) | 1986-06-04 | 1988-10-26 | Daiichi Seiyaku Co | Benzopyran derivatives |
| US5290780A (en) * | 1991-01-30 | 1994-03-01 | American Cyanamid Co. | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
| WO1992013535A1 (en) * | 1991-02-06 | 1992-08-20 | Research Corporation Technologies, Inc. | Anticonvulsant substituted quinazolones |
| US5958930A (en) | 1991-04-08 | 1999-09-28 | Duquesne University Of The Holy Ghost | Pyrrolo pyrimidine and furo pyrimidine derivatives |
| US5294617A (en) | 1993-04-23 | 1994-03-15 | American Cyanamid Company | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
| US5284853A (en) | 1993-04-23 | 1994-02-08 | American Cyanamid Company | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
| EP0635263A3 (en) | 1993-06-28 | 1995-09-27 | American Cyanamid Co | Angiotensin II antagonists (AII) as inhibitors of the growth of adipose tissue. |
| HUT68558A (en) | 1993-07-20 | 1995-06-28 | Chinoin Gyogyszer Es Vegyeszet | Method for preparing isoflavon derivatives |
| JPH09510695A (ja) | 1994-01-03 | 1997-10-28 | エイシア・ファーマシュウティカルズ，インコーポレイテッド | ８−アザ、６−アザ、および６，８−ジアザ−１，４−ジヒドロキノキサリン−２，３−ジオン類およびそのグリシン／ｎｍｄａリセプターに対するアンタゴニストとしての使用 |
| JPH07258224A (ja) | 1994-03-24 | 1995-10-09 | Dai Ichi Seiyaku Co Ltd | 二環性化合物 |
| US5756502A (en) * | 1994-08-08 | 1998-05-26 | Warner-Lambert Company | Quinazolinone derivatives as cholyecystokinin (CCK) ligands |
| CA2214131C (en) * | 1995-03-14 | 2009-06-23 | Novartis Ag | Trisubstituted phenyl derivatives |
| US5783577A (en) | 1995-09-15 | 1998-07-21 | Trega Biosciences, Inc. | Synthesis of quinazolinone libraries and derivatives thereof |
| WO1997028118A1 (en) | 1996-02-05 | 1997-08-07 | Hoechst Celanese Corporation | Process for preparing anthranilic acids |
| EP0920319A4 (en) | 1996-05-20 | 2002-05-02 | Merck & Co Inc | GONADOLIBERIN ANTAGONISTS |
| FR2750862B1 (fr) | 1996-07-12 | 1998-10-16 | Dupin Jean Pierre | Utilisation d'heterocycles diazotes fusionnes avec un systeme aromatique ou heteroaromatique pour le traitement des maladies thrombo-emboliques |
| WO1998018781A2 (en) | 1996-10-28 | 1998-05-07 | Versicor, Inc. | Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents |
| IT1289154B1 (it) | 1997-01-03 | 1998-09-29 | Chiesi Farma Spa | Derivati di isoflavone loro preparazione e loro impiego terapeutico |
| JPH10259176A (ja) * | 1997-03-17 | 1998-09-29 | Japan Tobacco Inc | 血管新生阻害作用を有する新規アミド誘導体及びその用途 |
| US5948775A (en) | 1997-03-19 | 1999-09-07 | American Home Products Corporation | 2- or 3-(substitutedaminoalkoxyphenyl)quinazolin-4-ones |
| WO1999009140A1 (en) | 1997-08-20 | 1999-02-25 | The Regents Of The University Of California | Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
| DE69910538T2 (de) | 1998-01-22 | 2004-06-24 | The Regents Of The University Of California, Oakland | Nukleinsäuresequenzen, welche für capsaicin-rezeptoren kodieren |
| CN1310706A (zh) | 1998-02-25 | 2001-08-29 | 遗传研究所有限公司 | 磷脂酶抑制剂 |
| US6500853B1 (en) | 1998-02-28 | 2002-12-31 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| WO2000050387A1 (en) * | 1999-02-22 | 2000-08-31 | Pacific Corporation | Vanilloid analogues containing resiniferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof |
| GB9920912D0 (en) | 1999-09-03 | 1999-11-10 | Indena Spa | Novel derivatives of flavones,xanthones and coumarins |
| WO2001070228A1 (en) | 2000-03-17 | 2001-09-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| CN1443170A (zh) | 2000-07-20 | 2003-09-17 | 神经原公司 | 辣椒素受体配体 |
| MXPA03001535A (es) * | 2000-08-21 | 2004-12-13 | Pacific Corp | Derivados de tiourea novedosos y las composiciones farmaceuticas que contienen los mismos. |
| FR2815033B1 (fr) | 2000-10-06 | 2003-09-05 | Negma Lab | Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique |
| EA007538B1 (ru) | 2000-12-11 | 2006-10-27 | Туларик Инк. | Антагонисты cxcr3 |
| SK11952003A3 (sk) | 2001-03-26 | 2004-03-02 | Novartis Ag | Deriváty pyridínu, spôsoby ich prípravy, farmaceutická kompozícia, ktorá ich obsahuje, a ich použitie |
| AU2002325381A1 (en) * | 2001-07-31 | 2003-02-24 | Bayer Healthcare Ag | Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| GB0128499D0 (en) | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
| IL147416A (en) * | 2001-12-31 | 2008-11-26 | Israel State | Combined modalities for improved cancer treatment |
| US7074805B2 (en) * | 2002-02-20 | 2006-07-11 | Abbott Laboratories | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| US7381730B2 (en) | 2002-03-15 | 2008-06-03 | Bristol-Myers Squibb Company | 3-arylquinazoline derivatives as selective estrogen receptor beta modulators |
| WO2003106435A1 (en) * | 2002-06-18 | 2003-12-24 | Sankyo Company, Limited | Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof |
| CN1665791A (zh) | 2002-07-05 | 2005-09-07 | 霍夫曼-拉罗奇有限公司 | 喹唑啉衍生物 |
| EP1398032A1 (en) | 2002-09-10 | 2004-03-17 | PheneX Pharmaceuticals AG | 4-Oxo-quinazolines as LXR nuclear receptor binding compounds |
| GB0223730D0 (en) | 2002-10-11 | 2002-11-20 | Novartis Ag | Organic compounds |
| CA2502302A1 (en) | 2002-11-04 | 2004-05-21 | Nps Pharmaceuticals, Inc. | Quinazolinone compounds as calcilytics |
| NZ541479A (en) | 2003-02-11 | 2008-11-28 | Vernalis Cambridge Liimited | Isoxazole compounds as inhibitors of heat shock proteins |
| JPWO2004078719A1 (ja) | 2003-03-06 | 2006-06-08 | 小野薬品工業株式会社 | インドール誘導体化合物およびその化合物を有効成分とする薬剤 |
| JP2006193426A (ja) | 2003-09-05 | 2006-07-27 | Sankyo Co Ltd | 置換された縮環ピリミジン−４（３ｈ）−オン化合物 |
| WO2005040112A1 (en) | 2003-10-14 | 2005-05-06 | Oxagen Limited | Compounds with pgd2 antagonist activity |
| US20070135454A1 (en) † | 2003-11-14 | 2007-06-14 | Tracy Bayliss | Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) |
| JP4102939B2 (ja) | 2004-02-13 | 2008-06-18 | 萬有製薬株式会社 | 縮環４−オキソ−ピリミジン誘導体 |
| GB0412769D0 (en) * | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
| GB0412768D0 (en) | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
| EP1881988A1 (en) | 2005-05-11 | 2008-01-30 | MERCK SHARP & DOHME LTD. | 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1) |
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| KR20100039410A (ko) | 2007-07-18 | 2010-04-15 | 노파르티스 아게 | Ｖｒ－１ 길항제 및 ｃｏｘ－２ 억제제의 상승적 조합물 |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
-
2004
- 2004-06-08 GB GBGB0412769.2A patent/GB0412769D0/en not_active Ceased
-
2005
- 2005-06-08 PT PT05750584T patent/PT1755606E/pt unknown
- 2005-06-08 KR KR1020107019024A patent/KR20100101017A/ko not_active Application Discontinuation
- 2005-06-08 NZ NZ551630A patent/NZ551630A/en unknown
- 2005-06-08 AU AU2005251476A patent/AU2005251476C1/en active Active
- 2005-06-08 SG SG200903909-0A patent/SG153811A1/en unknown
- 2005-06-08 SI SI200530141T patent/SI1755606T2/sl unknown
- 2005-06-08 KR KR1020067025788A patent/KR101018607B1/ko active IP Right Grant
- 2005-06-08 RU RU2006146632/04A patent/RU2396261C2/ru active
- 2005-06-08 DE DE602005003128T patent/DE602005003128T3/de active Active
- 2005-06-08 BR BRPI0511933A patent/BRPI0511933B8/pt active IP Right Grant
- 2005-06-08 JP JP2007526311A patent/JP4703650B2/ja active Active
- 2005-06-08 PL PL05750584T patent/PL1755606T5/pl unknown
- 2005-06-08 CA CA2567821A patent/CA2567821C/en active Active
- 2005-06-08 RU RU2010112450/04A patent/RU2449995C2/ru active
- 2005-06-08 MX MXPA06014249A patent/MXPA06014249A/es active IP Right Grant
- 2005-06-08 CN CN200580016187.3A patent/CN1956721B/zh active Active
- 2005-06-08 EP EP05750584A patent/EP1755606B2/en active Active
- 2005-06-08 DK DK05750584.4T patent/DK1755606T4/da active
- 2005-06-08 WO PCT/EP2005/006253 patent/WO2005120510A1/en active IP Right Grant
- 2005-06-08 US US11/569,802 patent/US7960399B2/en active Active
- 2005-06-08 AT AT05750584T patent/ATE376833T1/de active
- 2005-06-08 ES ES05750584T patent/ES2293584T5/es active Active
-
2006
- 2006-11-20 ZA ZA200609634A patent/ZA200609634B/xx unknown
- 2006-11-23 IL IL179532A patent/IL179532A/en active IP Right Grant
- 2006-12-07 EC EC2006007067A patent/ECSP067067A/es unknown
- 2006-12-07 TN TNP2006000405A patent/TNSN06405A1/en unknown
- 2006-12-28 MA MA29565A patent/MA28685B1/fr unknown
-
2007
- 2007-01-08 NO NO20070122A patent/NO338181B1/no unknown
- 2007-07-18 HK HK07107754A patent/HK1105577A1/xx active IP Right Maintenance
- 2007-12-20 HR HR20070577T patent/HRP20070577T4/hr unknown
-
2008
- 2008-01-03 CY CY20081100014T patent/CY1107846T1/el unknown
-
2009
- 2009-11-06 AU AU2009233684A patent/AU2009233684A1/en not_active Abandoned
-
2011
- 2011-01-21 JP JP2011010997A patent/JP5400812B2/ja active Active
- 2011-04-19 US US13/089,943 patent/US8211902B2/en active Active
-
2012
- 2012-02-14 EC ECSP12007067 patent/ECSP12007067A/es unknown
- 2012-03-29 US US13/434,248 patent/US8809528B2/en active Active
-
2014
- 2014-07-02 US US14/322,165 patent/US9102653B2/en active Active